Correlation Between Cns Pharmaceuticals and AnnexonInc

Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and AnnexonInc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and AnnexonInc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cns Pharmaceuticals and AnnexonInc, you can compare the effects of market volatilities on Cns Pharmaceuticals and AnnexonInc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of AnnexonInc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and AnnexonInc.

Diversification Opportunities for Cns Pharmaceuticals and AnnexonInc

0.42

Correlation Coefficient

Cns Pharmaceuticals  AnnexonInc

Very weak diversification

The 3 months correlation between Cns and AnnexonInc is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and AnnexonInc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AnnexonInc and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with AnnexonInc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AnnexonInc has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and AnnexonInc go up and down completely randomly.

Pair Corralation between Cns Pharmaceuticals and AnnexonInc

Given the investment horizon of 90 days Cns Pharmaceuticals is expected to under-perform the AnnexonInc. In addition to that, Cns Pharmaceuticals is 2.14 times more volatile than AnnexonInc. It trades about -0.01 of its total potential returns per unit of risk. AnnexonInc is currently generating about 0.05 per unit of volatility. If you would invest  330.00  in AnnexonInc on February 3, 2024 and sell it today you would earn a total of  158.00  from holding AnnexonInc or generate 47.88% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cns Pharmaceuticals  vs.  AnnexonInc

Cns Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Cns Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

AnnexonInc

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in AnnexonInc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, AnnexonInc showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cns Pharmaceuticals and AnnexonInc

The main advantage of trading using opposite Cns Pharmaceuticals and AnnexonInc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, AnnexonInc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnnexonInc will offset losses from the drop in AnnexonInc's long position.

The idea behind Cns Pharmaceuticals and AnnexonInc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.